Study of cardiovascular disease biomarkers among tobacco consumers. Part 3: evaluation and comparison with the US National Health and Nutrition Examination Survey

References

• Agaku IT, King BA, Husten CG, et al. (2014). Tobacco product use among adults—United States, 2012–2013. MMWR Morb Mortal Wkly Rep 63:542–7
   PubMed Web of Science ®Google Scholar
• Bolinder G, Norén A, de Faire U, Wahren J. (1997a). Smokeless tobacco use and atherosclerosis: an ultrasonographic investigation of carotid intima media thickness in healthy middle-aged men. Atherosclerosis 132:95–103
   PubMed Web of Science ®Google Scholar
• Bolinder G, Norén A, Wahren J, de Faire U. (1997b). Long-term use of smokeless tobacco and physical performance in middle-aged men. Eur J Clin Invest 27:427–33
   PubMedGoogle Scholar
• Calapai G, Caputi AP, Mannucci C, et al. (2009). Cardiovascular biomarkers in groups of established smokers after a decade of smoking. Basic Clin Pharmacol Toxicol 104:322–8
   PubMed Web of Science ®Google Scholar
• Campbell LR, Brown BG, Jones BA, et al. (2015). Study of cardiovascular disease biomarkers among tobacco consumers, Part 1: Biomarkers of exposure. Inhal Toxicol (in press)
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2010a). National Health and Nutrition Examination Survey Data. Available from: http://www.cdc.gov/nchs/nhanes.htm. [Last accessed: 3 Aug 2012]
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2010b). National Health and Nutrition Examination Survey Questionnaire (or Examination Protocol, or Laboratory Protocol). 2010b. Available from: http://www.cdc.gov/nchs/nhanes.htm. [Last accessed: 3 Aug 2012]
   Google Scholar
• Chao A, Thun MJ, Henley SJ, et al. (2002). Cigarette smoking, use of other tobacco products and stomach cancer mortality in US adults: the Cancer Prevention Study II. Int J Cancer 101:380–9
   PubMed Web of Science ®Google Scholar
• Eliasson M, Lundblad D, Hägg E. (1991). Cardiovascular risk factors in young snuff-users and cigarette smokers. J Intern Med 230:17–22
   PubMed Web of Science ®Google Scholar
• Eliasson M, Asplund K, Evrin PE, Lundblad D. (1995). Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study. Atherosclerosis 113:41–53
   PubMed Web of Science ®Google Scholar
• Ernster VL, Grady DG, Greene JC, et al. (1990). Smokeless tobacco use and health effects among baseball players. JAMA 264:218–24
   PubMed Web of Science ®Google Scholar
• Frost-Pineda K, Liang Q, Liu J, et al. (2011). Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. Nicotine Tob Res 13:182–93
   PubMed Web of Science ®Google Scholar
• Giraud DW, Martin HD, Driskell JA. (1995). Plasma and dietary vitamin C and E levels of tobacco chewers, smokers, and nonusers. J Am Diet Assoc 95:798–800
   PubMed Web of Science ®Google Scholar
• Hatsukami DK, Kotlyar M, Allen S, et al. (2005). Effects of cigarette reduction on cardiovascular risk factors and subjective measures. Chest 128:2528–37
   PubMed Web of Science ®Google Scholar
• Hatsukami DK, Benowitz NL, Rennard SI, et al. (2006). Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob Res 8:600–22
   PubMed Web of Science ®Google Scholar
• Henley SJ, Thun MJ, Connell C, Calle EE. (2005). Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Contr 16:347–58
   PubMed Web of Science ®Google Scholar
• Mansoor MA, Hervig T, Stakkestad JA, et al. (2011). Serum folate is significantly correlated with plasma cysteine concentrations in healthy industry workers. Ann Nutr Metab 58:68–73
   PubMedGoogle Scholar
• Mouhamed DH, Ezzaher A, Neffati F, et al. (2011). Effect of cigarette smoking on plasma homocysteine concentrations. Clin Chem Lab Med 49:479–83
   PubMed Web of Science ®Google Scholar
• Naufal ZS, Marano KM, Kathman SJ, Wilson CL. (2011). Differential exposure biomarker levels among cigarette smokers and smokeless tobacco consumers in the National Health and Nutrition Examination Survey 1999–2008. Biomarkers 16:222–35
   PubMed Web of Science ®Google Scholar
• National Cancer Institute (NCI). (1999). Health effects of exposure to environmental tobacco smoke. In: Smoking and tobacco control monograph no. 10. Available from: http://cancercontrol.cancer.gov/tcrb/monographs/10/. [Last accessed: 3 Aug 2012]
   Google Scholar
• Norberg M, Stenlund H, Lindahl B, et al. (2006). Contribution of Swedish moist snuff to the metabolic syndrome: a wolf in sheep's clothing? Scand J Public Health 34:576–83
   PubMed Web of Science ®Google Scholar
• Nordskog BK, Brown BG, Marano KM, et al. (2015). Study of cardiovascular disease biomarkers among tobacco consumers. Part 2: biomarkers of biological effect. Inhal Toxicol (in press)
   Google Scholar
• Nutt DJ, Phillips LD, Balfour D, et al. (2014). Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res 20:218–25
   PubMed Web of Science ®Google Scholar
• Okumura K, Tsukamoto H. (2011). Folate in smokers. Clin Chim Acta 412:521–6
   PubMed Web of Science ®Google Scholar
• Piano MR, Benowitz NL, Fitzgerald GA, et al. American Heart Association Council on Cardiovascular Nursing. (2010). Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment. A policy statement from the American Heart Association. Circulation 122:1520–44
   PubMed Web of Science ®Google Scholar
• Siegel D, Benowitz N, Ernster VL, et al. (1992). Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players. Am J Public Health 82:417–21
   PubMed Web of Science ®Google Scholar
• Silaste ML. (2003). Dietary effects on antioxidants, oxidised LDL and homocysteine. Dissertation Oulu University. Available from: http://herkules.oulu.fi/isbn9514270703/. [Last accessed: 3 Aug 2012]
   Google Scholar
• Stratton K, Shetty P, Wallace R, Bondurant S. (2001). Clearing the smoke: the science base for tobacco harm reduction – executive summary. Tob Control 10:189–95
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services (USDHHS). (2004). The health consequences of smoking: a report of the surgeon general. Available from: http://www.surgeongeneral.gov/library/reports/index.html. [Last accessed: 3 Aug 2012]
   Google Scholar
• US Department of Health and Human Services (USDHHS). (2010). How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease. Available from: http://www.ncbi.nlm.nih.gov/books/NBK53017/. [Last accessed: 11 Nov 2014]
   Google Scholar
• Wallenfeldt K, Hulthe J, Bokemark L, et al. (2001). Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year-old men. J Intern Med 250:492–501
   PubMed Web of Science ®Google Scholar
• Wennmalm A, Benthin G, Granström EF, et al. (1990). Relation between tobacco consumption and urinary excretion of thromboxane A2 and prostacyclin metabolites in 756 randomly sampled young men. In: Sameulsson B, Paoletti R. (eds.). Advances in prostaglandin, thromboxane, and leukotriene research. Vol. 21. New York: Raven Press Ltd, 615
   Google Scholar
• Zeller M, Hatsukami D, Strategic Dialogue on Tobacco Harm Reduction Group. (2009). The strategic dialogue on tobacco harm reduction: a vision and blueprint for action in the US. Tob Control 18:324–32
   PubMed Web of Science ®Google Scholar